The likelihood of experiencing an increase in Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index within 208 weeks was lower for patients in the ...
Patients with moderate to severe active systemic lupus erythematosus (SLE) who began treatment with anifrolumab in the TULIP-1 and TULIP-2 trials experienced a statistically significant reduction in ...
Dr. Geraldino’s areas of clinical and research interest include Systemic Lupus Erythematosus (Lupus), Rheumatoid Arthritis, and musculoskeletal ultrasonography. She has been supervising the Lupus ...
MedPage Today on MSN
Study: Helping lupus patients with money issues improves their health
Better patient-reported outcomes with social workers' assistance ...
Lower likelihood seen for experiencing increase in Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (HealthDay News) — For patients with moderately to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results